Register Here

2020 Lead Sponsor

IQVIA

2020 Executive Sponsors

Microsoft
Oracle Health Sciences
Parexel
Trialspark

2020 Associate Sponsors

BBK Worldwide
Clinical Ink
Clinical Pipe
Complion
Datacubed Health
EDETEK
Elligo
Greenphire
ICON
Inato
InterSystems
Lokavant
Medidata
MMG
PatientLink
physIQ
Quest Diagnostics
Saama
Science 37
Target Health
Tasso, Inc
THREAD Research
Trials.ai

2020 Showcase Sponsors

Langland
Preventice Solutions
Trialscope

2020 Supporting Sponsors

BrainBaseline
Inteliquet
Orbita

2020 Media Partners

Applied Clinical Trials
Clinical Leader
Pharmalicensing

Overview & Why Attend

Celebrating 10 years of DPHARM in a post Covid-19 world. 

DPHARM is the conference that challenges and reports on innovation to shake up the way we do clinical trials to reduce patient/physician burden and drive greater efficiencies. We challenge how we want clinical trials to look by 2030 and share examples from those who are doing something about it. We highlight major opportunities to fundamentally change how clinical trials are operationalized going forward.

DPHARM in a Post Covid-19 World

As we get through Covid-19, we have to expedite modern technology, innovative and strategic efforts to give patients flexibility to participate in clinical trials. We need to collect data and monitor from afar as well as to help companies develop clinical protocols that limit clinic visits and so much more.

Celebrating 10 Years Virtually

In 2020 we celebrate the 10th annual anniversary of DPHARM virtually. It is our job to provide the best possible virtual experience. We are developing an agenda that reflects the urgency of much-needed changes in drug development through the reporting of innovative examples. We are pleased to announce thus so far: 

2020 Plenary Speakers & Chair



Pharma Companies Reporting on Innovation from the Trenches

These companies reported on a specific example of innovation applied to advance clinical trials within the last 12 months. Each company addressed the milestones, challenges and problems with adoption. The 2019 companies included:

  • Allergan
  • Amgen
  • BMS
  • Boehringer Ingelheim
  • Celgene
  • Eli Lilly
  • Genentech
  • Janssen
  • Novartis
  • Pfizer
  • Takeda
  • Sanofi

2020 Topics Include

   
  • Data, Transparency & Inclusivity
  • Data Science and its Expected Impact on Medicine Development
  • Decentralized Trials
  • Rapid Deployment and Scaling of Technologies 
  • Direct to Patient Trials
  • Leading through Covid-19
  • Partnering Effectively in a Digital Ecosystem
  • Managing Digital Across Different Divisions
  • The Economics of Incentives
  • Advances in Platform Trials
  • Advances in Developing Digital Endpoints

 

8 Track Choices

  1. Advances in Data Driven Efforts
  2. Flexible/Decentralized Clinical Trials
  3. Way Beyond eSource
  4. Data, AI and Machine Learning
  5. Advances in Digital Endpoints
  6. Innovative Digital Solutions
  7. Innovative Patient Solutions
  8. Where are they now?

DPHARM Idol Disrupt

DPHARM Idol Disrupt is a series of quick fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provides amazing shared learnings on how to properly assess new technologies. This section of DPHARM kicks off with an update from the 2019 Winner, Tasso. with their Co-Founder and CEO, Ben Casavant, PhD who will give an update on where they are a year later. 

DPHARM Idol Disrupt Judges Include


Esther Dyson, Executive Founder, Way to Wellville

Cindy Geoghegan, Patient Advocate

Yusuf Ghadiali, Senior Director, Global Clinical Operations, Biogen

Hassan Kadhim, Director, Head of Clinical Trial Business Capabilities, Bristol-Myers Squibb

Joe Kim, MBA, Senior Advisor, Clinical Operations and Digital Registry, Digital Health Office, Translational Technology & Innovation, Eli Lilly & Company

Ülo Palm, MD, PhD, Former SVP, Head, Digital Science, Allergan

Chandra Ramanathan, MBA, PhD, Global Head, Pharma R&D Open Innovation, Bayer Healthcare 

Douglas Schantz, VP, Clinical Operations, Alexion 

Jessica Scott, MD, Head of R&D Patient Engagement Office, Takeda Pharmaceuticals

Mark Travers, PhD, MBA, VP, Head of GCTO Regions, Monitoring Excellence, Global Operations, Merck & Co.

Networking & Exhibits in a Virtual Setting

DPHARM will provide a partnering networking tool to set up meetings before, during and after DPHARM. Support services will be available to help you make the most of virtual networking. DPHARM will also have a wide choice of group ZOOM meetings and a guide to quick fire exhibit presentations.

DPHARM Commitment 


  • DPHARM combines TED-style talks with fireside chats, quick fires, panels and demos presentations showcasing innovations from leading Pharma R&D practitioners and from other industries.
  • DPHARM underscores the promise and challenge of innovation in advancing drug development.
  • DPHARM features new models and collaborations to get therapeutics to patients faster.
  • DPHARM features the full spectrum of clinical research options and utilizes insights more appropriately.
  • DPHARM is dedicated to challenging creative solutions and finding a way to implement them.
  • DPHARM explores to whom companies are being disruptive and to gain a better understanding of the impact on clinical trials.

Let us know if you have any questions at service@tcfllc.org. We look forward to sharing the 2020 agenda soon!

Sincerely,

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Business Development

Jennifer Moran B&W1

Jennifer Moran
Producer

Elizabeth Bard B&W-47

Elizabeth Bard
Business Development Manager

Adam Kolanko
Business Development Manager

Meg

Meg Gould
Senior Conference Planner

Allyson Adams
Marketing Manager

Efrosini Zambas
Associate Meeting Planner

 

 

The Most Advanced Conference on Challenging New Ideas for Clinical Trials

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave


Testimonials

  • "The amount of innovations presented for clinical research was both staggering and inspiring."

    - Ulo Palm, Allergan

  • "Wow! What a great event. So many interesting people and CRAACO is such a brilliant movement. I am inspired by so many of the people and presentations that I saw. Congrats...bringing together amazing people at conferences with a mission."

    - Dave Bjork, Patient Advocate

  • "DPharm is truly a first class event and we are thrilled to have been a part of it. We extracted tremendous value and look forward to expanding our role in future events. Best event of the year."

    - Ryan Tubbs, Microsoft

  • "Loved the conference. I learned so much and can’t wait to share lessons learned with my colleagues at the Scleroderma Foundation."

    - Joan Meissner, Patient Advocate

  • "Really great presentations (almost Ted-talk like set up); enjoyed the information sharing and inspirational patient speakers (also great that there were patients/advocates attending as well)."

    - Danielle DeVico, Biogen

  • "Patient Keynote was very touching. I liked the richness of the content. Greatly produced."

    - Hassan Kadhim, BMS

  • "DPharm is the go to place to connect with innovators in pharma research."

    - Joe Kim, Eli Lilly

  • "An informative meeting with great networking. I like the style of presentations, the cutting edge presentations and opening with inspirational stories."

    - Megan McBride, Janssen

  • "Thanks for making it happen again. Great event, growing attendance, and more importantly increasing quality."

    - Tomasz Sablinski, MD, PhD, Transparency Life Sciences

  • "Unencumbered access to some incredibly brilliant minds, brought together by the obvious enjoyment they have in collaborating. I found the event quite inclusive. Thank you for making this a valuable learning experience."

    - Marilyn Pratt, Medidata

  • "Congratulations on a very successful conference."

    - Chandra Ramanathan, Bayer HealthCare, LLC

  • "Thank you! It was great...as usual!"

    - Solomon Babani, BioPharma Solutions

  • "What an amazing meeting. So impressed!"

    - John Brownstein, PhD, Boston Children’s Hospital

  • "Thank you for putting together such a great event. It was a pleasure working with each of you.It was a great experience."

    - Amy Ripston, 4G Clinical

  • "Thanks and congrats again for a great DPharm2016, proud to have been part of this years edition."

    - Bert Hartog, Janssen

  • "Thank you for making DPharm a valuable learning experience."

    - Marilyn Pratt, Medidata Solutions

  • "Dpharm was a must attend event for those looking at embedding Systemic Thinking and disruptive innovation into their work models."

    - Michelle Shogren, Bayer

  • "I love coming back to DPharm as the 2014 edition changed my life. It was my first time at DPharm and prior to my attendance, I was working on innovation related to the way we design clinical trials. I recall being absolutely amazed by the spirit of collaboration. After the conference was over, I spent my Saturday connecting with speakers and attendees on Linkedin, thinking: I want to be part of this community! Two years later, my dream came true...I come back to find respected colleagues that became friends and collaborations, to exchange ideas and learn from each other!"

    - Attendee, DPharm 2016